Pura Vida Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Pura Vida Investments’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,361	Closed	-$2.26M	–	319
2021 Q4	$2.26M	Buy	24,361 +4,361	+22%	+$287K	0.08%	145
2021 Q3	$1.19M	Buy	+20,000	New	+$1.18M	0.04%	210
2018 Q2	–	Sell	-50,000	Closed	-$1.98M	–	120
2018 Q1	$1.98M	Buy	50,000 +22,017	+79%	+$856K	1.17%	30
2017 Q4	$951K	Sell	27,983 -83,717	-75%	-$2.38M	0.4%	58
2017 Q3	$2.85M	Buy	111,700 +76,700	+219%	+$1.76M	0.83%	49
2017 Q2	$590K	Buy	+35,000	New	+$480K	0.23%	57

Pura Vida Investments's ARNA Position: Q1 2022 in Review

Pura Vida Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 24,361 shares — an estimated $2.26M sold.

Pura Vida Investments first reported a position in ARNA in Q2 2017 and held it in 6 quarters. The position peaked at $2.85M in Q3 2017. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Pura Vida Investments reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Pura Vida Investments sold 24,361 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.26M.
Pura Vida Investments first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 6 quarters.
Pura Vida Investments's Arena Pharmaceuticals Inc position peaked at $2.85M in Q3 2017.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.